Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
What Alzheimer’s Biomarkers Reveal in Black and Hispanic Americans
Japan Gives Conditional Approval to First Stem Cell Therapy for Parkinson’s
Does Childhood Cancer Accelerate Brain Aging Later in Life?
Could Targeting Gum Disease Bacteria Slow Alzheimer’s?
Tau Blood Biomarkers May Signal Faster Cognitive Decline in Women
Syngenta Halts Production on Controversial Pesticide Linked to Parkinson’s
FDA’s Rewrites the Rules for Promising Huntington’s Gene Therapy
Heidi Hall Is Defying the GRN Gene That Caused Dementia in Her Family
Tau Tangling Speed May Predict Progression in PSP and Other Dementias
Frontotemporal Dementia Is Often Misdiagnosed — New Tests Could Help
The Race to Treat Genetic FTD: New Therapies Target the GRN Mutation
A Single Blood Test May Predict When Alzheimer’s Symptoms Will Begin
What is Progressive Supranuclear Palsy? The Rare Dementia that Rev. Jesse Jackson Had
Does Menopause Hormone Replacement Therapy Affect Dementia Risk?
Many With Dementia Still Receive Inappropriate Medications, Study Finds
Previous
1
2
3
Next
Page load link
Go to Top